Blink-powered glasses could keep an eye on health
October 12, 2026
The ultra-low-power design could pave the way for smart glasses that continuously monitor health without constant charging.
The ultra-low-power design could pave the way for smart glasses that continuously monitor health without constant charging.
Urolution Medical is preparing comparative clinical trials to evaluate catheter performance and patient outcomes.
A research team led by professor Chan Kui-ming from the Department of Biomedical Sciences at CityUHK discovered that H2BE113K, a missense H2B mutation, promotes colony formation and lung metastasis in breast cancer.
In a new study, Broad Institute researchers report that two small-molecule chemicals that reduce oxygen delivery to cells improved symptoms of neurodegeneration in a mouse model of Parkinson’s disease.
Northwestern Medicine scientists have identified a stem-like state in small-cell lung cancer that distinguishes a group of patients with exceptionally poor outcomes following chemoimmunotherapy, according to a study published in Cell Reports Medicine.
Diseases such as Alzheimer’s and frontotemporal dementia are considered neurodegenerative tauopathies, in which tau proteins in the brain misfold and lead to cognitive decline. Until now, it has been unclear how misfolded tau recruits other seemingly healthy tau and causes it to misfold and clump.
Johns Hopkins University engineers have created robots the size of a pencil tip intended to travel through the body to deliver medicine to infections inside a beating heart.
Stopping a cancer cell from dividing does not necessarily make it harmless. Chemotherapy can leave behind living, senescent cells. These ‘zombie’ cells can release inflammatory signals, helping tumors resist treatment. Drugs that eliminate these lingering cells could help, but they can also harm other cells.
RANCHO CUCAMONGA, Calif., Oct. 6, 2026 /PRNewswire/ — New World Medical is pleased to announce the Ahmed® Glaucoma Valve (AGV), Ahmed ClearPath® (ACP), and KDB GLIDE® have received Medical Device Regulation (MDR) certification in the European Union.
Combination of Hēlo Thrombectomy System and Hēlo Return establish the first 510(k)-cleared platform compatible with continuous vacuum aspiration